Issued Patents All Time
Showing 25 most recent of 139 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12358928 | Compounds, compositions and methods | Anthony A. Estrada, Jianwen A. Feng, Brian M. Fox, Colin Phillip Leslie, Alfonso Pozzan +2 more | 2025-07-15 |
| 12240846 | 5- and 6-azaindole compounds for inhibition of Bcr-Abl tyrosine kinases | Samuel Kintz, Li Ren | 2025-03-04 |
| 12214058 | Imaging methods using deuterated compounds | Jan Marik, Simon Williams | 2025-02-04 |
| 12171739 | N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases | Julie Marie Hicks, Fredrik P. Marmsater, Qian Zhao | 2024-12-24 |
| 11858926 | Inhibiting agents for bruton's tyrosine kinase | Brian T. Hopkins, Bin Ma, Robin Prince, Isaac Marx, Fengmei Zheng +2 more | 2024-01-02 |
| 11840529 | Substituted pyrimidines as LRKK2 inhibitors | Anthony A. Estrada, Jianwen A. Feng, Zachary K. Sweeney, Javier de Vicente Fidalgo | 2023-12-12 |
| 11834439 | Compounds, compositions, and methods | Javier de Vicente Fidalgo, Anthony A. Estrada, Jianwen A. Feng, Zachary K. Sweeney | 2023-12-05 |
| 11807638 | 5- and 6-azaindole compounds for inhibition of Bcr-Abl tyrosine kinases | Samuel Kintz, Li Ren | 2023-11-07 |
| 11807649 | Fused tetracyclic quinazoline derivatives as inhibitors of ErbB2 | Samuel Kintz, Li Ren, Qiang Su | 2023-11-07 |
| 11767321 | 5- and 6-azaindole compounds for inhibition of BCR-ABL tyrosine kinases | Samuel Kintz, Li Ren | 2023-09-26 |
| 11591316 | Compounds, compositions, and methods | Javier de Vicente Fidalgo, Anthony A. Estrada, Jianwen A. Feng, Zachary K. Sweeney | 2023-02-28 |
| 11572356 | Biaryl inhibitors of Bruton's tyrosine kinase | Brian T. Hopkins, Bin Ma, Timothy Chan, Lihong Sun, Lei Zhang +3 more | 2023-02-07 |
| 11504440 | Deuterated compounds | Jan Marik, Simon Williams | 2022-11-22 |
| 11427577 | Inhibiting agents for Bruton's tyrosine kinase | Brian T. Hopkins, Bin Ma, Robin Prince, Isaac Marx, Fengmei Zheng +2 more | 2022-08-30 |
| 11427561 | IRAK4 inhibiting agents | Timothy Chan, Kevin M. Guckian, Tracy J. Jenkins, Jermaine Thomas, Jeffrey Vessels +6 more | 2022-08-30 |
| 11236046 | Substituted heterocyclic sulfonamide compounds useful as TRPA1 modulators | Huifen Chen, Yanyan Chu, Steven Do, Anthony A. Estrada, Baihua Hu +7 more | 2022-02-01 |
| 11214565 | Compound, compositions, and methods | Anthony A. Estrada, Jianwen A. Feng, Zachary K. Sweeney, Javier de Vicente Fidalgo | 2022-01-04 |
| 11174273 | Quinazoline analogs as receptor tyrosine kinase inhibitors | Eli M. Wallace, George T. Topalov, Alexandre Joseph Buckmelter, Qian Zhao | 2021-11-16 |
| 11129832 | Biheteroaryl compounds and uses thereof | Anthony Estrada, Liting Dong, Kevin X. Chen, Paul Gibbons, Malcolm Huestis +7 more | 2021-09-28 |
| 11111235 | Compounds, compositions, and methods | Javier de Vicente Fidalgo, Anthony A. Estrada, Jianwen A. Feng, Zachary K. Sweeney | 2021-09-07 |
| 11028080 | Substituted pyrimidines as LRKK2 inhibitors | Anthony A. Estrada, Jianwen A. Feng, Zachary K. Sweeney, Javier de Vicente Fidalgo | 2021-06-08 |
| 10961237 | Inhibiting agents for Bruton's tyrosine kinase | Brian T. Hopkins, Bin Ma, Robin Prince, Isaac Marx, Fengmei Zheng +2 more | 2021-03-30 |
| 10780073 | N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases | Julie Marie Hicks, Fredrik P. Marmsater, Qian Zhao | 2020-09-22 |
| 10766878 | Sulfonylcycloalkyl carboxamide compounds | Baihua Hu, Vishal Verma, Matthew Volgraf, Anthony A. Estrada | 2020-09-08 |
| 10759783 | Biaryl inhibitors of Bruton'S tyrosine kinase | Brian T. Hopkins, Bin Ma, Timothy Chan, Lihong Sun, Lei Zhang +3 more | 2020-09-01 |